MX2019009655A - Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos. - Google Patents

Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos.

Info

Publication number
MX2019009655A
MX2019009655A MX2019009655A MX2019009655A MX2019009655A MX 2019009655 A MX2019009655 A MX 2019009655A MX 2019009655 A MX2019009655 A MX 2019009655A MX 2019009655 A MX2019009655 A MX 2019009655A MX 2019009655 A MX2019009655 A MX 2019009655A
Authority
MX
Mexico
Prior art keywords
immunosuppressants
immunological disorders
plant extracts
treating immunological
extracts enriched
Prior art date
Application number
MX2019009655A
Other languages
English (en)
Inventor
Werneck Guimarães Cristiano Ruch
Carlos Eduardo Vitor
Lisandra Ravanelli Pessa
Romulo Dragani Reis
Alessandra Mascarello
Fernando Henrique De Souza Gama
Original Assignee
Ache Laboratorios Farmaceuticos Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ache Laboratorios Farmaceuticos Sa filed Critical Ache Laboratorios Farmaceuticos Sa
Publication of MX2019009655A publication Critical patent/MX2019009655A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/47—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/92—Unsaturated compounds containing keto groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La invención describe extractos de plantas del género Stachytarpheta enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunológicos. También se describen compuestos activos aislados y un proceso de producción de los mismos.
MX2019009655A 2017-02-17 2018-02-19 Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos. MX2019009655A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR102017003318A BR102017003318A2 (pt) 2017-02-17 2017-02-17 compostos, processo de produção de compostos, extrato enriquecido, frações ativas de extrato enriquecido, processo de produção de extrato enriquecido, método de seleção de biomassa vegetal para produção de extrato enriquecido, composição e uso para tratamento de desordens imunológicas
PCT/BR2018/050037 WO2018148816A2 (en) 2017-02-17 2018-02-19 Compounds, process of production of compounds, enriched extract, enriched extract active fractions, enriched extract process of production, method for selecting vegetal biomass for enriched extract production, composition and use for treatment of immunological disorders

Publications (1)

Publication Number Publication Date
MX2019009655A true MX2019009655A (es) 2020-07-24

Family

ID=61282932

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019009655A MX2019009655A (es) 2017-02-17 2018-02-19 Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos.
MX2022012282A MX2022012282A (es) 2017-02-17 2019-08-13 Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022012282A MX2022012282A (es) 2017-02-17 2019-08-13 Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos.

Country Status (27)

Country Link
US (1) US20200231561A1 (es)
EP (2) EP3583103B1 (es)
JP (2) JP7349362B2 (es)
KR (1) KR20190121790A (es)
CN (1) CN110475768B (es)
AU (2) AU2018221956B2 (es)
BR (2) BR102017003318A2 (es)
CA (1) CA3052713A1 (es)
CL (1) CL2019002309A1 (es)
CO (1) CO2019008891A2 (es)
CY (1) CY1125187T1 (es)
DK (1) DK3583103T3 (es)
EC (1) ECSP19058322A (es)
ES (1) ES2909387T3 (es)
HR (1) HRP20220377T1 (es)
IL (1) IL268732A (es)
LT (1) LT3583103T (es)
MX (2) MX2019009655A (es)
PE (1) PE20200449A1 (es)
PL (1) PL3583103T3 (es)
PT (1) PT3583103T (es)
RS (1) RS63162B1 (es)
SA (1) SA519402443B1 (es)
SG (1) SG11201907375VA (es)
SI (1) SI3583103T1 (es)
WO (1) WO2018148816A2 (es)
ZA (1) ZA201906106B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115304652A (zh) * 2022-07-25 2022-11-08 福建华闽晟业生物科技有限公司 一种利用巨菌草制备野芝麻新甙的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3703543A (en) * 1969-11-05 1972-11-21 American Home Prod Hydroxamic acids of alicyclic amino acids
DE3030477C2 (de) * 1980-08-12 1986-10-16 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Iridoid-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung
JPH0366682A (ja) * 1989-08-04 1991-03-22 Tsumura & Co 新規イリドイド誘導体
KR927003493A (ko) * 1990-10-09 1992-12-18 주식회사 쓰무라 이리도이드 유도체 및 그의 의약으로서의 사용
DE19644422C2 (de) * 1996-10-25 2000-06-15 Stefan Schulz Verwendung von Terpenen zur Behandlung von Autoimmunkrankheiten und bei Transplantat-Abstoßungsreaktionen
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
CN100391465C (zh) * 2002-05-10 2008-06-04 科学与工业研究委员会 2′-对-羟基苯甲酰基莫司诺斯酸的肝脏保护活性
EP1371372A1 (de) * 2002-06-08 2003-12-17 Cognis Iberia, S.L. Verwendung von Wirkstoffgemischen enthaltend Tocopherole und Extrakte des Harpagophytum procumbens zur Herstellung eines Medikamentes gegen rheumatische Arthritis
JP2008024670A (ja) * 2006-07-24 2008-02-07 Daiwa Kagaku Kogyo Kk 害虫駆除剤
BRPI0700767B8 (pt) * 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa composição farmacêutica, produto farmaceutico, processo para obtenção de compostos farmaceuticos e uso de tais compostos para o tratamento do vitiligo
CN103120699B (zh) * 2011-11-18 2017-04-19 天津市国际生物医药联合研究院 环烯醚萜类化合物在制备抗sars的药物中的应用
CN103690551A (zh) * 2013-07-18 2014-04-02 江苏大学 猪殃殃中环烯醚萜苷提取物及其提取方法和医药用途
DE102015102020A1 (de) * 2015-02-12 2016-08-18 Renate Wilmanowicz Immunologisch aktives Phyto-Gemisch und seine Anwendung bei der Prävention und in einem Verfahren zur Behandlung von Effloreszenzen

Also Published As

Publication number Publication date
WO2018148816A2 (en) 2018-08-23
KR20190121790A (ko) 2019-10-28
EP3583103B1 (en) 2022-01-12
EP4001270A1 (en) 2022-05-25
ZA201906106B (en) 2020-08-26
RU2019129095A (ru) 2021-03-17
LT3583103T (lt) 2022-04-25
ES2909387T3 (es) 2022-05-06
CA3052713A1 (en) 2018-08-23
BR112019017128A2 (pt) 2020-04-14
CY1125187T1 (el) 2023-06-09
BR102017003318A2 (pt) 2018-10-30
SI3583103T1 (sl) 2022-07-29
JP7349362B2 (ja) 2023-09-22
AU2022201835A1 (en) 2022-04-07
MX2022012282A (es) 2022-10-27
EP3583103A2 (en) 2019-12-25
ECSP19058322A (es) 2019-10-31
CN110475768A (zh) 2019-11-19
PL3583103T3 (pl) 2022-08-01
WO2018148816A3 (en) 2018-10-18
AU2018221956B2 (en) 2022-03-24
CL2019002309A1 (es) 2020-05-29
WO2018148816A4 (en) 2019-01-03
DK3583103T3 (da) 2022-03-14
SG11201907375VA (en) 2019-09-27
JP2023061959A (ja) 2023-05-02
CN110475768B (zh) 2023-12-01
AU2018221956A1 (en) 2019-08-29
US20200231561A1 (en) 2020-07-23
PE20200449A1 (es) 2020-02-28
PT3583103T (pt) 2022-03-25
JP2020507607A (ja) 2020-03-12
CO2019008891A2 (es) 2020-01-17
RS63162B1 (sr) 2022-05-31
SA519402443B1 (ar) 2023-02-08
IL268732A (en) 2019-10-31
HRP20220377T1 (hr) 2022-07-08
RU2019129095A3 (es) 2021-10-27

Similar Documents

Publication Publication Date Title
NZ734714A (en) Methods of purifying cannabinoids, compositions and kits thereof
SG10201804868PA (en) Compounds for the inhibition of indoleamine-2,3-dioxygenase
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
MX2022013651A (es) Composiciones y metodos para mejorar la produccion de tomate.
MX2023004969A (es) Metodos para tratar y prevenir infeccion por c. difficile.
MX2021000151A (es) Metodo para obtener saponinas a partir de plantas.
MX2020000523A (es) Compuestos de isocromano y usos de los mismos.
WO2018081806A3 (en) Compositions and methods for impeding transcription of expanded microsatellite repeats
PH12019500198A1 (en) Compounds and compositions and uses thereof
MX2022002269A (es) Plantas transformadas y metodos para elaborar y utilizar las mismas.
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
MX2022012282A (es) Extractos de plantas enriquecidos con derivados de ipolamiida como inmunosupresores para el tratamiento de trastornos inmunologicos.
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
IL289971A (en) Improved methods for the production of plants
ITUA20163883A1 (it) Metodo per proteggere seme o corpo della pianta che cresce da seme contro artropodi parassiti.
MD893Y (ro) Procedeu de tratare a seminţelor de ceapă comună înainte de semănat
MY183891A (en) Medicinal ambrosia plant extracts
WO2017198455A3 (en) Method for increasing yield in beta spp. plants
AU2016200094A1 (en) Multi-bracted lavender plants
AU2019902745A0 (en) Improved methods for the production of plants
AU2019902138A0 (en) Treatment of C4 photosynthesising plants
AU2021901148A0 (en) Improved methods for the production of plants
EP3663309C0 (en) STEROID GLYCOSIDES EXTRACTED FROM THE FURCRAEA FOETIDA PLANT FOR THE TREATMENT OF SKIN CONDITIONS
AU2018902163A0 (en) Treatment of C4 photosynthesising plants
AU2016224843A8 (en) Compositions and combinations for the treatment of angiogenesis diseases and disorders